Predictors of cinacalcet discontinuation and reinitiation in hemodialysis patients: results from 7 European countries.

Nephrologist discontinuation of cinacalcet therapy is common in European countries. Additional research is needed to identify optimal cinacalcet treatment strategies for SHPT management, including comparisons of intermittent cinacalcet therapy versus sustained treatment with reduced dose or frequency.